DM
MYOV

Deerfield Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Deerfield Management’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-400,685
Closed -$6.2M – 109
2017
Q3 		$6.2M Hold
400,685
– – 0.28% 74
2017
Q2 		$4.69M Sell
400,685
-304,583
-43% -$3.77M 0.25% 68
2017
Q1 		$8.28M Sell
705,268
-791,407
-53% -$9.07M 0.32% 76
2016
Q4 		$18.6M Buy
+1,496,675
New +$17.3M 0.77% 43

Other funds holding MYOV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NCM
NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Deerfield Management's MYOV Position: Q4 2017 in Review

Deerfield Management sold out of Myovant Sciences Ltd. (MYOV) in Q4 2017, closing a stake of 400,685 shares — an estimated $6.2M sold.

Deerfield Management first reported a position in MYOV in Q4 2016 and held it in 4 quarters. The position peaked at $18.6M in Q4 2016. 36 funds tracked by Wall St. Rank hold MYOV as of Q4 2017.

  • Deerfield Management reported no remaining Myovant Sciences Ltd. position as of Q4 2017 after selling out during the quarter.
  • Deerfield Management sold 400,685 Myovant Sciences Ltd. shares in Q4 2017, an estimated $6.2M.
  • Deerfield Management first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 4 quarters.
  • Deerfield Management's Myovant Sciences Ltd. position peaked at $18.6M in Q4 2016.
  • 36 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2017.

Based on Deerfield Management's 13F filing for Q4 2017, filed 14 Feb 2018.